These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24217402)

  • 1. Relation between N-terminal pro-brain natriuretic peptide levels and response to enhanced external counterpulsation in chronic angina pectoris.
    Sahlén A; Wu E; Rück A; Hagerman I; Förstedt G; Sylvén C; Berglund M; Jernberg T
    Coron Artery Dis; 2014 Jan; 25(1):45-51. PubMed ID: 24217402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris.
    Kumar A; Aronow WS; Vadnerkar A; Sidhu P; Mittal S; Kasliwal RR; Trehan N
    Am J Ther; 2009; 16(2):116-8. PubMed ID: 19300038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina.
    Campbell AR; Satran D; Zenovich AG; Campbell KM; Espel JC; Arndt TL; Poulose AK; Boisjolie CR; Juusola K; Bart BA; Henry TD
    Am Heart J; 2008 Dec; 156(6):1217-22. PubMed ID: 19033023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced external counterpulsation - effect on angina pectoris, QoL and exercise capacity after 1 year.
    May O; Lynggaard V; Mortensen JC; Malczynski J
    Scand Cardiovasc J; 2015 Feb; 49(1):1-6. PubMed ID: 25471629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina.
    Loh PH; Louis AA; Windram J; Rigby AS; Cook J; Hurren S; Nikolay NP; Caplin J; Cleland JG
    J Intern Med; 2006 Mar; 259(3):276-84. PubMed ID: 16476105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry).
    Michaels AD; Barsness GW; Soran O; Kelsey SF; Kennard ED; Hui JC; Lawson WE;
    Am J Cardiol; 2005 Feb; 95(3):394-7. PubMed ID: 15670552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry).
    Soran O; Kennard ED; Kfoury AG; Kelsey SF;
    Am J Cardiol; 2006 Jan; 97(1):17-20. PubMed ID: 16377276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
    Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the International EECP Patient Registry (IEPR).
    Michaels AD; Kennard ED; Kelsey SE; Holubkov R; Soran O; Spence S; Chou TM
    Clin Cardiol; 2001 Jun; 24(6):453-8. PubMed ID: 11403506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enhanced external counterpulsation on dobutamine-induced left ventricular wall motion abnormalities in severe chronic angina pectoris.
    Bagger JP; Hall RJ; Koutroulis G; Nihoyannopoulos P
    Am J Cardiol; 2004 Feb; 93(4):465-7. PubMed ID: 14969625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive left ventricular energetics during enhanced external counterpulsation.
    Michaels AD; Tacy T; Teitel D; Shapiro M; Grossman W
    Am J Ther; 2009; 16(3):239-46. PubMed ID: 19145208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris.
    Wu E; Mårtensson J; Desta L; Broström A
    Clin Cardiol; 2021 Feb; 44(2):160-167. PubMed ID: 33400292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of enhanced external counterpulsation on resting oxygen uptake in patients having previous coronary revascularization and in healthy volunteers.
    Ochoa AB; deJong A; Grayson D; Franklin B; McCullough P
    Am J Cardiol; 2006 Sep; 98(5):613-5. PubMed ID: 16923446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.